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Abstract
Correction to Gupta P K, Prabhakar S, Sharma S, Anand A. Vascular endothelial growth factor-A (VEGF-A) and
chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients. Journal of Neuroinflammation 8:47.
Correction
The authors observe that, in Table two of our study [1],
crude ORs and adjusted ORs for serum VEGFA were
also repeated for CSF VEGFA, however, these values for
CSF VEGFA are different from serum VEGFA. Correct
OR values of CSF VEGFA are given below.
Smoking: [crude OR(95% CI) = 1.7 (0.3-9.1), p = 0.4;
adj OR (95% CI) = 0.6 (0.08-4.4), p = 0.6].
Alcohol consumption: [crude OR(95% CI) = 0.6 (0.1-
2.2), p = 0.4; adj OR (95% CI) = 0.8 (0.1-4.4), p = 0.8].
Meat consumption: [crude OR(95% CI) = 2.2 (0.6-7.7),
p = 0.2; adj OR (95% CI) = 2.1 (0.5-7.7), p = 0.2].
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